Alimera Sciences (ALIM) Reports First Quarter 2013 Financial Results
5/10/2013 6:33:54 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ATLANTA, May 9, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by